Inhaled anesthetic use was popularized during the COVID-19 sedative shortages, and interest persisted due to an association ...

A week after Doug Ford (our provincial version of Trump, in every sense of the word) handily won the premiership of Ontario ...

The FDA has granted Fast Track designation to PP-01 for the mitigation of cannabis withdrawal symptoms in patients with cannabis use disorder.

Targeting final FDA approval of YUTREPIA™ after expiration of regulatory exclusivity on May 23, 2025Advancing pipeline of inhaled treprostinil ...

Products must note that they can increase blood pressure, but boxed warnings about adverse cardiovascular events can be ...

Vivani Medical completed enrollment in its LIBERATE-1 trial, testing a six-month GLP-1 implant for weight management.

The PREDICT-HFpEF tool predicts cardiovascular risk, and finerenone remains effective for heart failure across baseline risk levels.

Pharmacist involvement in primary care chronic disease co-management of hypertension and T2D improved patients' blood ...

Explore the intricate relationship between therapeutic CPAP pressures and obstructive sleep apnea severity in children, ...

Biogen Inc. ( NASDAQ: BIIB) Stifel 2025 Virtual CNS Forum Conference March 18, 2025 10:15 AM ET Great. Good morning, everybody. Happy to be moderating my annual panel where Priya has to listen to me ...

Trevi Therapeutics (TRVI) announced topline results from its Phase 2a RIVER trial of Haduvio for the treatment of patients with RCC. Haduvio ...